FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

NCT05791396 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Enterobacteriaceae Infections
Multi-antibiotic Resistance

Interventions

BIOLOGICAL: Donor - FMT
OTHER: Placebo FMT

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS